#LifeStyle

Skin Cancer Apps Don’t Work Accurately : Fed Trade Commission

Listen to this article

Smart phones are offering a lot like tech oriented applications, but a wave of art phone is still unable to tell you about the broken bone, sickness, or about the melanoma. The Federal trade commission is very active nowadays and have been backing the smart phones companies, who have been claiming that, their smart phones are capable to diagnose about Skin Cancer or melanoma, and this is severe form of deadly cancer, and due to the claim of the smart phone company, thousands of people have purchased this application.

skin cancer appsHow this app works is just as, it requires a snap shot of a mole on your skin, and along with this, you have to provide you with the certain information, and this app will detect, hoe are the possible chances that mole is cancerous. On the other hand, FTC has claimed that, this app does not offer the testing, which could show them as same about the apps work.

FTC’s bureau od consumer protection, Jassica Rich said “ Truth also implies in the mobile phone apps and its marketing.” App developers and the marketers of the product should have the sound knowledge and scientific knowledge to support any health and disease claims, which are being made by the application developers, in this way, this is always one of the best thing available for the customer in serving the right product, which could cater their needs same as claim and expectations.

Promoters of Melapp and Mole Detective agreed to settle the charges by the FTC of deceptive marketing, and with their charge, they are also being prohibited to claim which have not any scientific back ground and evidences.

Though, FTC is fully determined to stop these sorts of shits from the marketers. FTC said, it is going to suing the business man of UK  Avrom and Avi and his company, L Health, as the company could not fulfill the promise  and what they have promised with the people. LAsarwo also took over the marketing campaign of the mole detective app in August 2012, and this will now be charged with fine.

Mole detective app developer Kristi Kimball and her company sold out the customer solutions, and sold out the application from Jan 2012 until Lasarow and his company stepped in. Kimball and customer solutions agreed to settle the claims and ordered to return the $4000 back in app sales. Mole detective has been sold for up to $4.99 in Apple’s app store and Google’s rival Google play.

Along with this, there have been sold for up to $4.99 in Apple’s app store and Google’s rival Google Play. Moreover, Melapp Health discovery has also committed to settle prohibited misleading claims, and FTC has ordered to pay back the $18000. In this way, company will settle all the illegal transactions, and this amount will be returned to the people, who are taking this advantage.